ADAMA(SZ:000553)2025-10-29 11:35Financial Performance - The company's revenue for Q3 2025 was 6,654,225 thousand RMB, representing a 0.62% increase compared to the same period last year[13]. - The net loss attributable to shareholders for Q3 2025 was (342,454) thousand RMB, a 63.69% improvement year-over-year[13]. - The EBITDA for Q3 2025 was 741,865 thousand RMB, reflecting an 87.42% increase compared to the same period last year[13]. - Q3 2025 revenue was $933 million, showing a year-over-year change of 0%, while revenue for the first nine months was $3.025 billion, reflecting a year-over-year decrease of 0%[14]. - Operating revenue for the current period reached ¥21,678,425, an increase of 0.72% compared to ¥21,523,293 in the previous period[31]. - Operating loss decreased to ¥(436,660), improving from a loss of ¥(1,492,552) in the previous period[31]. - Net loss for the current period was ¥(422,806), significantly reduced from ¥(1,838,112) in the previous period, marking an improvement of approximately 77%[31]. - The total comprehensive loss for the current period was ¥(456,414), compared to ¥(2,067,869) in the previous period, indicating a significant reduction in losses[31]. - Basic earnings per share improved to ¥(0.1815) from ¥(0.7890) in the previous period[31]. Cash Flow and Expenses - The operating cash flow for the first nine months of 2025 was 2,373,860 thousand RMB, down 17.06% compared to the previous year[6]. - Financial expenses for the first nine months of 2025 totaled RMB 1.544 billion ($215 million), up from RMB 1.22 billion ($172 million) in the same period of 2024[20]. - Total financial expenses net for the first nine months of 2025 was RMB 1.54 billion ($215 million), compared to RMB 1.456 billion ($205 million) in 2024, reflecting an increase due to a one-time gain in the previous year[21]. - Cash flow from operating activities generated a net amount of ¥2,373,860, down from ¥2,862,232 in the previous period[32]. - Cash flow from investing activities resulted in a net outflow of ¥(942,083), compared to a net outflow of ¥(866,420) in the previous period[33]. - Cash flow from financing activities showed a net outflow of ¥(1,408,310), improving from a net outflow of ¥(2,703,059) in the previous period[33]. Assets and Liabilities - The total assets at the end of Q3 2025 were 49,930,633 thousand RMB, a decrease of 0.26% from the end of the previous year[6]. - As of September 30, 2025, total current assets amount to 26,262,900 thousand RMB, compared to 25,917,390 thousand RMB at the end of 2024[30]. - Total current liabilities increased to 20,468,589 thousand RMB from 18,013,457 thousand RMB year-over-year[30]. - Non-current assets total 23,667,733 thousand RMB, down from 24,142,387 thousand RMB at the end of 2024[30]. - Total liabilities amount to 31,477,288 thousand RMB, compared to 31,068,683 thousand RMB at the end of 2024[30]. - The company's equity attributable to shareholders is 18,453,345 thousand RMB, down from 18,991,094 thousand RMB at the end of 2024[30]. - Short-term borrowings increased by 34.65% to RMB 6.394 billion ($910 million) due to debt replacement[24]. - Long-term borrowings decreased by 33.40% to RMB 1.443 billion ($204 million) as a result of partial debt repayment[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 36,215, including 24,837 A-share shareholders and 11,378 B-share shareholders[27]. - The largest shareholder, Syngenta Group Co., Ltd., holds 78.47% of the shares, totaling 1,828,137,961 shares[27]. - The company has no significant changes in the shareholding structure of the top 10 shareholders compared to the previous period[27]. Market Environment - The company noted that geopolitical tensions have not significantly impacted its supply capabilities or financial performance[11]. - The overall market environment remains challenging, with pricing pressures due to oversupply of raw materials affecting demand[10]. - The Asia-Pacific region saw a significant decline in Q3 2025 sales, down 16% to $225 million, with China specifically dropping 17% to $91 million[15]. - In Q3 2025, North America sales increased by 4% to $164 million, while sales for the first nine months rose by 15% to $659 million[15]. Operational Efficiency - The company reported a gross profit margin improvement, with operating costs decreasing by 5.67% in Q3 2025 compared to Q3 2024[13]. - Gross profit and gross margin improved year-over-year in Q3 2025 due to enhanced operational efficiency and reduced inventory costs, despite the negative impact of price declines[18]. - Operating expenses slightly decreased in Q3 2025, primarily due to the absence of one-time litigation costs from the previous year, although restructuring and consulting expenses increased[19]. - Research and development expenses for the first nine months of 2025 were 307,417 thousand RMB, a decrease of 3.93% year-over-year[12]. Financial Instruments - The company reported a significant decrease in derivative financial assets by 30.81% year-over-year, primarily due to the disposal and revaluation of derivatives[24]. Audit Information - The company did not undergo an audit for the third quarter report[34].